Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Allogeneic T-cell therapy for autoimmune diseases – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Allogeneic T-cell therapy for autoimmune diseases, historical and forecasted epidemiology as well as the Allogeneic T-cell therapy for autoimmune diseases market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Liver Disease Therapeutic Market Report by Therapy Type (Anti-Rejection Drugs/Immunosuppressants, Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobulins, Corticosteroids, and Anti-Viral Drugs) Disease Type (Non-alcoholic Fatty Liver Disease (NAFLD), Viral Hepatitis (B, C, D), Alcoholic Liver Disease (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032
... (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032 The market for Liver Disease Therapeutics is predicted to reach US$ 28.98 billion in 2032, increasing at a ... Read More
-
Antiphospholipid Syndrome (APS) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Antiphospholipid Syndrome (APS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Antiphospholipid Syndrome (APS) market report provides current ... Read More
-
Systemic Lupus Erythematosus Market Insight, Epidemiology And Market Forecast - 2034
... drug applications submitted to the US FDA for cancer therapies are successful, and for brain cancer, the rate of success has been closer to 1% over the past two decades. Currently, there is an estimation ... Read More
-
Adult-onset Still Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Adult-onset Still Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Adult-onset Still Disease market report provides current ... Read More
-
Eczema – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Eczema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Eczema market report provides current treatment practices, emerging drugs, Eczema market share of the individual ... Read More
-
Global Human Microbiome Market Report by Application (Therapeutics, Diagnostics) Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, Other Diseases) Product (Probiotics, Prebiotics, Symboitics, Other Products), Countries and Company Analysis, 2024-2032
... Human Microbiome Market will grow US$ 3.05 Billion by 2032 from US$ 0.72 Billion in 2023, with a CAGR of 17.48% during 2023-2032. The human microbiome is a collection of microorganisms found on and within ... Read More
-
Autoimmune Uveitis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune Uveitis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Stem Cell Therapy Market, By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others), By Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Others), By End User (Hospitals, Cell Banks , Academic and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... , Academic and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Stem cell therapy is a promising and emerging field in regenerative medicine that involves the use of ... Read More
-
Global Autoimmune Disease Treatment Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Autoimmune Disease Treatment industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Autoimmune Disease Treatment. The report also introduces players ... Read More
-
Global Immunoglobulin Products Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Pemphigus Vulgaris Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... to reach US$ 519.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.3% during 2024-2034. The pemphigus vulgaris market has been comprehensively analyzed in IMARC's new report titled "Pemphigus Vulgaris Market: Epidemiology, Industry Trends, ... Read More
-
Global Immunomodulators Databank Market Report
... segment is expected to be the highest contributor to this market, with $78,020.3 Million in 2020, and is anticipated to reach $151,171.1 Million by 2029, registering a CAGR of 7.67%. Oncology and Respiratory segments collectively ... Read More
-
Middle East and Africa Stem Cell Therapy Market, By Type (Allogenic Stem Cell Therapy, Autologous Stem Cell Therapy); By Cell Source (Adipose Tissue-Derived MSCs, Bone Marrow-derived MSCs, Placental/Umbilical Cord-derive MSCs); By Therapeutic Application (Musculoskeletal Disorders, Wounds & Surgeries, Cardiovascular Diseases, Inflammatory & Autoimmune, Neurological Disorders); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Middle East and Africa (MEA)), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Wounds & Surgeries, Cardiovascular Diseases, Inflammatory & Autoimmune, Neurological Disorders); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Middle East and Africa (MEA)), Trend Analysis, Competitive Landscape & Forecast, ... Read More
-
Blood Testing Market by Type (Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels), Application (Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders), End-User - Global Forecast 2024-2030
... USD 94.49 billion in 2023 and expected to reach USD 100.02 billion in 2024, at a CAGR 6.34% to reach USD 145.37 billion by 2030. Blood testing is a clinical procedure that involves analyzing a ... Read More
-
Specialty Injectable Generics Market Size, Trends, Analysis, and Outlook By Type (Drugs, Biologics), By Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... Generics market size is poised to register 8.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Specialty Injectable Generics market across By ... Read More
-
miRNA Sequencing and Assay Market Size, Trends, Analysis, and Outlook By Products and Services (Products, Services), By Technology (Sequencing By Synthesis, Sequencing By Oligonucleotide Ligation and Detection (SOLiD), Nanopore Sequencing, Sanger Sequencing, Single Molecule Real-time (SMRT) Sequencing), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-User (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), by Country, Segment, and Companies, 2024-2032
... (SMRT) Sequencing), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-User (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), by Country, Segment, and ... Read More
-
Hematology Market Size, Trends, Analysis, and Outlook By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers, Others), By Reagent (Coagulation Reagents, Flow Cytometry Reagents, Immun-hematology Reagents, Others), By Application (Drug Testing, Auto-immune Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032
... Diseases, Cancer, Diabetes Mellitus, Infectious Diseases, Others), By End-User (Hospitals, Clinical Testing Institutes, Patient Self-testing, Others), by Country, Segment, and Companies, 2024-2032 The global Hematology market size is poised to register 5.8% growth from 2024 ... Read More
-
Biomarker Technologies Market Size, Trends, Analysis, and Outlook By Product (Instruments, Assay and Reagents, Consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, Others), By Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032
... Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032 The global Biomarker Technologies market size is poised to register 14.1% growth from 2024 to 2032, presenting significant growth prospects ... Read More
-
Biotechnology Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Others), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufacturing), By Scale of Operation (Commercial Operations, Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Others), by Country, Segment, and Companies, 2024-2032
... Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, ... Read More
-
Biosimilars Market Size, Trends, Analysis, and Outlook By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Blood Disorders, Growth Hormonal Deficiency, Rheumatoid Arthritis, Chronic & Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... 2024-2032 The global Biosimilars market size is poised to register 12.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosimilars market across ... Read More
-
Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2024-2032
... market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 172.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9.4% during 2024-2032. The rising number of ... Read More
-
Global Autoimmune Uveitis Market - 2023-2030
... forecast period 2023-2030. A rare but potentially dangerous eye disorder known as autoimmune uveitis is characterized by inflammation of the uvea, the central layer of the eye. Autoimmune uveitis can develop in any area of ... Read More
-
Autoimmune Gastritis - Pipeline Insight, 2024
... picture of the Autoimmune Gastritis pipeline landscape is provided, which includes the disease overview and Autoimmune Gastritis treatment guidelines. The assessment part of the report embraces in-depth Autoimmune Gastritis commercial assessment and clinical assessment of ... Read More
-
Autoimmune Hepatitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
Research Assistance
